Shilpa Medicare jumped 6.36% to Rs 470.75 after the firm said that its wholly owned subsidiary, Shilpa Biologicals has filed its first Drug Master File (DMF) of recombinant Human Albumin 20% with the United States Food and Drug Administration.
| Subscribe To Our Free Newsletter |
